Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes

被引：27
|
作者：
Pang, Huiwen [1 ]
Huang, Xiangquan [1 ]
Xu, Zhi Ping [1 ]
Chen, Chen [2 ]
Han, Felicity Y. [1 ]
机构：
[1] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia
[2] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld, Australia
来源：
DRUG DISCOVERY TODAY | 2023年 / 28卷 / 01期
关键词：
Oral insulin; Poly(lactic co-glycolic acid) (PLGA); Biological barriers; Mucus; Epithelium; Gastrointestinal tract (GIT); CELL-PENETRATING PEPTIDES; DRUG-DELIVERY; POLYMERIC NANOPARTICLES; INTRACELLULAR FATE; IN-VITRO; MUCUS; CHITOSAN; SECRETION; PEG; ABSORPTION;
D O I：
10.1016/j.drudis.2022.103393
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Currently, the only practical way to treat type 1 and advanced insulin-dependent type 2 diabetes mellitus (T1/2DM) is the frequent subcutaneous injection of insulin, which is significantly different physiologically from endogenous insulin secretion from pancreatic islets and can lead to hyperinsu-linemia, pain, and infection in patients with poor compliance. Hence, oral insulin delivery has been actively pursued to revolutionize the treatment of insulin-dependent diabetes. In this review, we provide an overview of recent progress in developing poly(lactic co-glycolic acid) (PLGA) nanoparticles (NPs) for oral insulin delivery. Different strategies for insulin-loaded PLGA NPs to achieve normo-glycemic effects are discussed. Finally, challenges and future perspectives of PLGA NPs for oral insulin delivery are put forward.
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [41] Oral insulin-delivery system for diabetes mellitus
    Kanzarkar, Minakshi
    Pathak, Prem Prakash
    Vaidya, Mandar
    Brumlik, Charles
    Choudhury, Abhishek
    PHARMACEUTICAL PATENT ANALYST, 2015, 4 (01) : 29 - 36
  • [42] Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin
    Yin, YaShu
    Chen, DaWei
    Qiao, MingXi
    Lu, Zhe
    Hu, HaiYang
    JOURNAL OF CONTROLLED RELEASE, 2006, 116 (03) : 337 - 345
  • [43] Progress of Oral Insulin and Related Drug Delivery Systems and their Pharmacokinetics
    Chen, Jingjing
    Liu, Rui
    Liu, Changxiao
    Jin, Xin
    Zhang, Qinghua
    Wang, Jialu
    Zhao, Fang
    Wang, Ze
    Qiu, Haiyan
    Li, Yazhuo
    Yi, Xiulin
    CURRENT DRUG METABOLISM, 2018, 19 (10) : 863 - 870
  • [44] Design and development of a biocompatible montmorillonite PLGA nanocomposites to evaluate in vitro oral delivery of insulin
    Lal, Seema
    Perwez, Ahmad
    Rizvi, Moshahid A.
    Datta, Monika
    APPLIED CLAY SCIENCE, 2017, 147 : 69 - 79
  • [45] Preparation and in vitro evaluation of linear and star-branched PLGA nanoparticles for insulin delivery
    Davaran, Soodabeh
    Omidi, Yadollah
    Rashidi, Mohammad Reza
    Anzabi, Maryam
    Shayanfar, Ali
    Sohrab, Ghyasvand
    Vesal, Nezamaldin
    Davaran, Farzaneh
    JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2008, 23 (02) : 115 - 131
  • [46] PLGA nanoparticles for nasal drug delivery
    Alghareeb, Salah
    Asare-Addo, Kofi
    Conway, Barbara R.
    Adebisi, Adeola O.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 95
  • [47] Cellular delivery of PEGylated PLGA nanoparticles
    Pamujula, Sarala
    Hazari, Sidhartha
    Bolden, Gevoni
    Graves, Richard A.
    Chinta, Dakshinamurthy Devanga
    Dash, Srikanta
    Kishore, Vimal
    Mandal, Tarun K.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (01) : 61 - 67
  • [48] Engineered PLGA nanoparticles for the delivery of SiRNA
    Enlow, Elizabeth M.
    Ropp, Patricia A.
    Tian, Shaomin
    DeSimone, Joseph M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [49] PLGA-microsphere delivery of insulin and IGRP epitopes as a therapy for type 1 diabetes
    Racine, Jeremy J.
    Leeth, Caroline M.
    Serreze, David V.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [50] Comparison and process optimization of PLGA, chitosan and silica nanoparticles for potential oral vaccine delivery
    Amin, Muhammad K.
    Boateng, Joshua S.
    THERAPEUTIC DELIVERY, 2019, 10 (08) : 493 - 514
12345